ClockΔ19小鼠作为双相障碍动物模型的表面效度与预测效度:系统综述
该系统综述遵循PRISMA指南,检索PubMed和Embase,从1281条记录中纳入22项研究,评估ClockΔ19小鼠作为双相障碍动物模型的表面效度与预测效度。结果显示该小鼠行为表型以多动、焦虑样行为减少、抑郁样行为减少和奖励刺激偏好增加为特征,与人类躁狂高度一致,且表现出快速情绪循环;慢性锂盐给药可逆转多数双相样特征和神经生物学异常。结论认为ClockΔ19小鼠具有实质性的表面效度,预测效度主要通过锂盐挑战研究评估,尚需进一步研究其他心境稳定治疗的反应。
要点
- ClockΔ19小鼠行为表型与人类躁狂高度一致,具有实质性表面效度。
- 该小鼠表现出快速情绪循环,与双相障碍临床特征一致。
- 慢性锂盐可逆转多数双相样特征和神经生物学异常,但其他治疗预测效度尚待研究。
核心结论
- ClockΔ19小鼠作为双相障碍动物模型具有实质性的表面效度,预测效度主要基于锂盐挑战研究。
研究设计与样本
- 遵循PRISMA指南的系统综述,检索PubMed和Embase数据库,从1281条记录中纳入22项研究。
主要发现
- ClockΔ19小鼠行为表型以多动、焦虑样行为减少、抑郁样行为减少和奖励刺激偏好增加为特征,与人类躁狂高度一致。
- ClockΔ19小鼠表现出快速情绪循环,即白天躁狂样表型、夜间心境正常,与双相障碍一致。
- 慢性给予锂盐可逆转ClockΔ19小鼠的多数双相样特征和大多数神经生物学异常。
临床怎么用
- ClockΔ19小鼠可作为研究双相障碍躁狂样表型和锂盐反应的有效临床前模型。
局限性
- 预测效度主要仅通过锂盐挑战研究评估,需进一步研究丙戊酸盐、拉莫三嗪、卡马西平、奥卡西平、抗精神病药、电休克治疗及各种光照干预的反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mice carrying the circadian locomotor output cycles Kaput delta 19 N-ethyl-N-nitrosoure (ENU) mutation (ClockΔ19) are used as an animal model for bipolar disorder (BD). We aimed to systematically review the face validity (phenotypical and pathophysiological resemblance with BD) and predictive validity (responsiveness to treatments used in BD) of this model in adherence with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. We carried out a systematic search of the databases PubMed and Embase, combining search terms covering BD and ClockΔ19. The 22 studies included in the review (from a total of 1281 identified records) show that the behavioral phenotype of the ClockΔ19 mouse is characterized by hyperactivity, decreased anxiety-like behavior, decreased depression-like behavior and increased preference for rewarding stimuli. This is highly consistent with mania in humans. Moreover, the ClockΔ19 mouse exhibits rapid mood cycling (a manic-like phenotype during the day followed by euthymia at night), which is consistent with BD. Chronic administration of lithium, a drug with well established mood-stabilizing effect in humans with BD, reverses the majority of the bipolar-like traits and most of the neurobiological abnormalities observed in the ClockΔ19 mouse. In conclusion, the ClockΔ19 mouse has substantial face validity as an animal model for BD. The predictive validity of the ClockΔ19 mouse has primarily been investigated via studies using lithium challenge. Therefore, further studies are needed to determine how the ClockΔ19 mouse responds to other mood-stabilizing treatments of BD such as valproate, lamotrigine, carbamazepine, oxcarbazepine, antipsychotics, electroconvulsive therapy and various light interventions.
引用
- Kristensen M, Nierenberg AA, Østergaard SD, et al. Face and predictive validity of the ClockΔ19 mouse as an animal model for bipolar disorder: a systematic review. Mol Psychiatry. 2017. PMID: 29112195. doi:10.1038/mp.2017.192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。